• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烧伤脓毒症中可溶性CD14亚型(可溶性髓系细胞触发受体-1)的评估

Evaluation of soluble CD14 subtype (presepsin) in burn sepsis.

作者信息

Cakır Madenci Özlem, Yakupoğlu Sezer, Benzonana Nur, Yücel Nihal, Akbaba Derya, Orçun Kaptanağası Asuman

机构信息

Dr. Lütfi Kırdar Kartal Research and Training Hospital, Biochemistry Laboratory, İstanbul, Turkey.

Dr. Lütfi Kırdar Kartal Research and Training Hospital, Burn Center Anaesthesia and Reanimation Clinic, Turkey.

出版信息

Burns. 2014 Jun;40(4):664-9. doi: 10.1016/j.burns.2013.08.024. Epub 2013 Sep 26.

DOI:10.1016/j.burns.2013.08.024
PMID:24074718
Abstract

BACKGROUND

Diagnosing sepsis is difficult in burn patients because of the inflammatory mediators that alter postburn metabolic profile. Here, we compare a new marker presepsin with procalcitonin (PCT), c-reactive protein (CRP) and white blood cell (WBC) in diagnosis and follow up of sepsis in burn patients.

METHODS

Patients admitted to burn center of our institute were prospectively investigated. Presepsin, PCT, CRP and WBC levels were measured at admission and every 6h for first day and daily thereafter. At all timing samples, patients were classified as sepsis or non-sepsis according to the current American Burn Association Consensus Criteria (ABA) 2007.

RESULT

37 adult patients were evaluated. A total data of 611 time points were supplied. Sepsis time points differ significantly from non-sepsis in presepsin (p < 0.0001), PCT (p = 0.0012) and CRP (p < 0.0001) levels. Non-surviving patient results differ significantly from survivors in presepsin (p < 0.0001), PCT (p = 0.0210) and CRP (p = 0.0008). AUC-ROC % values for diagnosing sepsis were 83.4% for presepsin, 84.7% for PCT, 81.9% for CRP and 50.8% for WBC. Sepsis patients had significantly different presepsin, CRP and WBC but not PCT levels on their first day of sepsis compared to previous days.

CONCLUSION

Plasma presepsin levels have comparable performance in burn sepsis.

摘要

背景

由于炎症介质会改变烧伤后的代谢状况,烧伤患者的脓毒症诊断较为困难。在此,我们比较一种新的标志物可溶性髓系细胞触发受体-1(presepsin)与降钙素原(PCT)、C反应蛋白(CRP)和白细胞(WBC)在烧伤患者脓毒症诊断及随访中的作用。

方法

对我院烧伤中心收治的患者进行前瞻性研究。入院时及入院后第一天每6小时、之后每天检测presepsin、PCT、CRP和WBC水平。在所有时间点的样本中,根据2007年美国烧伤协会共识标准(ABA)将患者分为脓毒症组或非脓毒症组。

结果

对37例成年患者进行了评估。共提供了611个时间点的全部数据。脓毒症时间点的presepsin(p < 0.0001)、PCT(p = 0.0012)和CRP(p < 0.0001)水平与非脓毒症组有显著差异。非存活患者的presepsin(p < 0.0001)、PCT(p = 0.0210)和CRP(p = 0.0008)结果与存活患者有显著差异。诊断脓毒症的曲线下面积(AUC-ROC)百分比值,presepsin为83.4%,PCT为84.7%,CRP为81.9%,WBC为50.8%。脓毒症患者在脓毒症第一天的presepsin、CRP和WBC水平与前几天相比有显著差异,但PCT水平无差异。

结论

血浆presepsin水平在烧伤脓毒症诊断中具有相当的性能。

相似文献

1
Evaluation of soluble CD14 subtype (presepsin) in burn sepsis.烧伤脓毒症中可溶性CD14亚型(可溶性髓系细胞触发受体-1)的评估
Burns. 2014 Jun;40(4):664-9. doi: 10.1016/j.burns.2013.08.024. Epub 2013 Sep 26.
2
Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.几种生物标志物在脓毒症患者管理中的作用:C 反应蛋白、降钙素原、前降钙素原和肾上腺髓质中段肽。
Clin Chem Lab Med. 2016 Jan;54(1):163-8. doi: 10.1515/cclm-2015-0243.
3
Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis.术前诊断腹腔感染中可溶性 CD14 亚型(sCD14-ST)的作用。
Clin Chem Lab Med. 2013 Oct;51(10):2053-62. doi: 10.1515/cclm-2013-0061.
4
Pathfast presepsin assay for early diagnosis of systemic inflammatory response syndrome in patients with nephrolithiasis.用于肾结石患者全身炎症反应综合征早期诊断的Pathfast降钙素原检测
Biomed Res Int. 2015;2015:792572. doi: 10.1155/2015/792572. Epub 2015 Feb 4.
5
Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.血清淀粉样蛋白前体是预测脓毒症患者临床结局的早期监测生物标志物。
Clin Chim Acta. 2016 Sep 1;460:93-101. doi: 10.1016/j.cca.2016.06.030. Epub 2016 Jun 25.
6
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.可溶性CD14亚型(前降钙素)在重症监护治疗第一周对严重脓毒症和脓毒性休克的诊断及预后评估价值
Crit Care. 2014 Sep 5;18(5):507. doi: 10.1186/s13054-014-0507-z.
7
[Early diagnostic value of Presepsin in sepsis: a prospective study on a population with suspected sepsis in fever clinics].前降钙素原在脓毒症中的早期诊断价值:发热门诊疑似脓毒症患者的前瞻性研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Apr;36(4):340-344. doi: 10.3760/cma.j.cn121430-20230828-00700.
8
Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases.脓毒症烧伤病例与非脓毒症烧伤病例白细胞、血沉、C反应蛋白及降钙素原血清水平的比较
Burns. 2008 Sep;34(6):770-4. doi: 10.1016/j.burns.2008.01.014. Epub 2008 May 29.
9
[The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].[不同促炎因子在血流感染患者脓毒症早期诊断中的诊断价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Mar;26(3):165-70. doi: 10.3760/cma.j.issn.2095-4352.2014.03.008.
10
Comparison of procalcitonin and C-reactive protein as markers of sepsis.降钙素原与C反应蛋白作为脓毒症标志物的比较
Crit Care Med. 2003 Jun;31(6):1737-41. doi: 10.1097/01.CCM.0000063440.19188.ED.

引用本文的文献

1
Early Detection, Diagnosis, Prevention, and Treatment of Infection to Avoid Sepsis and Septic Shock in Severely Burned Patients: A Narrative Review.严重烧伤患者感染的早期检测、诊断、预防及治疗以避免脓毒症和感染性休克:一篇叙述性综述
Eur Burn J. 2025 Feb 6;6(1):6. doi: 10.3390/ebj6010006.
2
Biomarkers of sepsis in burn injury: an update.烧伤后脓毒症的生物标志物:最新进展
Burns Trauma. 2025 Jan 16;13:tkae080. doi: 10.1093/burnst/tkae080. eCollection 2025.
3
Presepsin Does Not Predict Risk of Death in Sepsis Patients Admitted to the Intensive Care Unit: A Prospective Single-Center Study.
前降钙素不能预测入住重症监护病房的脓毒症患者的死亡风险:一项前瞻性单中心研究。
Biomedicines. 2024 Oct 11;12(10):2313. doi: 10.3390/biomedicines12102313.
4
Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis.降钙素原与中期促肾上腺皮质激素在诊断脓毒症或脓毒性休克中的比较:系统评价和荟萃分析。
BMC Infect Dis. 2023 May 5;23(1):288. doi: 10.1186/s12879-023-08262-4.
5
Role of CD14 in human disease.CD14 在人类疾病中的作用。
Immunology. 2023 Jul;169(3):260-270. doi: 10.1111/imm.13634. Epub 2023 Mar 27.
6
Use of procalcitonin as a biomarker for sepsis in pediatric burns.降钙素原作为小儿烧伤脓毒症生物标志物的应用。
Eur J Pediatr. 2023 Apr;182(4):1561-1567. doi: 10.1007/s00431-023-04831-6. Epub 2023 Feb 8.
7
Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs.抗生素管理的现状及生物标志物在抗生素管理计划中的作用
Infect Chemother. 2022 Dec;54(4):674-698. doi: 10.3947/ic.2022.0172.
8
A bibliometric analysis of publications on burn sepsis using VOSviewer.使用VOSviewer对烧伤脓毒症相关出版物的文献计量分析。
Front Med (Lausanne). 2022 Sep 14;9:971393. doi: 10.3389/fmed.2022.971393. eCollection 2022.
9
Modern Aspects of Burn Injury Immunopathogenesis and Prognostic Immunobiochemical Markers (Mini-Review).烧伤免疫发病机制与预后免疫生化标志物的现代研究进展(综述)
BioTech (Basel). 2022 May 27;11(2):18. doi: 10.3390/biotech11020018.
10
Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.降钙素原和前降钙素在非感染性器官衰竭、脓毒症和感染性休克中的诊断和预后价值:根据 Sepsis-3 定义的前瞻性观察研究。
BMC Infect Dis. 2022 Jan 4;22(1):8. doi: 10.1186/s12879-021-07012-8.